DCOY · Decoy Therapeutics Inc.
$2.90
-0.07 (-2.36%)
At close · Aug 28
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The lack of revenue from product sales to date and recurring losses from operations since its inception raise substantial doubt as to the Company's ability to continue as a going concern. Based on Decoy's expected cash requirements, Decoy believes that there is substantial doubt that its existing cash and cash equivalents, will be sufficient to fund its operations through one year from the financial statements' issuance date.”View the 10-Q filed Aug 12, 2026
Market Cap
$1.90M
Shares
655,185
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding DCOY
4 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | FSMAX | 5,156 | $45,888 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 4,034 | $29,004 | 0.00% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 477 | $4,245 | 0.00% | Long | 2026-05-31 | |
| Horizon Kinetics Medical ETF | MEDX | 21 | $149 | 0.00% | Long | 2026-06-30 |
Showing 1–4 of 4 positions